Titre : Tétrapyrroles

Tétrapyrroles : Questions médicales fréquentes

Termes MeSH sélectionnés :

Evidence-Based Practice
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tétrapyrroles : Questions médicales les plus fréquentes", "headline": "Tétrapyrroles : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tétrapyrroles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-25", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tétrapyrroles" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés macrocycliques", "url": "https://questionsmedicales.fr/mesh/D047028", "about": { "@type": "MedicalCondition", "name": "Composés macrocycliques", "code": { "@type": "MedicalCode", "code": "D047028", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chlorophylle", "alternateName": "Chlorophyll", "url": "https://questionsmedicales.fr/mesh/D002734", "about": { "@type": "MedicalCondition", "name": "Chlorophylle", "code": { "@type": "MedicalCode", "code": "D002734", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.374" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chlorophylle A", "alternateName": "Chlorophyll A", "url": "https://questionsmedicales.fr/mesh/D000077194", "about": { "@type": "MedicalCondition", "name": "Chlorophylle A", "code": { "@type": "MedicalCode", "code": "D000077194", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.374.140" } } }, { "@type": "MedicalWebPage", "name": "Chlorophyllides", "alternateName": "Chlorophyllides", "url": "https://questionsmedicales.fr/mesh/D002735", "about": { "@type": "MedicalCondition", "name": "Chlorophyllides", "code": { "@type": "MedicalCode", "code": "D002735", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.374.180" } } }, { "@type": "MedicalWebPage", "name": "Phéophytines", "alternateName": "Pheophytins", "url": "https://questionsmedicales.fr/mesh/D010674", "about": { "@type": "MedicalCondition", "name": "Phéophytines", "code": { "@type": "MedicalCode", "code": "D010674", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.374.700" } } }, { "@type": "MedicalWebPage", "name": "Protochlorophyllide", "alternateName": "Protochlorophyllide", "url": "https://questionsmedicales.fr/mesh/D011521", "about": { "@type": "MedicalCondition", "name": "Protochlorophyllide", "code": { "@type": "MedicalCode", "code": "D011521", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.374.725" } } } ] }, { "@type": "MedicalWebPage", "name": "Corrinoïdes", "alternateName": "Corrinoids", "url": "https://questionsmedicales.fr/mesh/D045728", "about": { "@type": "MedicalCondition", "name": "Corrinoïdes", "code": { "@type": "MedicalCode", "code": "D045728", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.437" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vitamine B12", "alternateName": "Vitamin B 12", "url": "https://questionsmedicales.fr/mesh/D014805", "about": { "@type": "MedicalCondition", "name": "Vitamine B12", "code": { "@type": "MedicalCode", "code": "D014805", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.437.777" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hydroxocobalamine", "alternateName": "Hydroxocobalamin", "url": "https://questionsmedicales.fr/mesh/D006879", "about": { "@type": "MedicalCondition", "name": "Hydroxocobalamine", "code": { "@type": "MedicalCode", "code": "D006879", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.437.777.560" } } } ] }, { "@type": "MedicalWebPage", "name": "Hydroxocobalamine", "alternateName": "Hydroxocobalamin", "url": "https://questionsmedicales.fr/mesh/D006879", "about": { "@type": "MedicalCondition", "name": "Hydroxocobalamine", "code": { "@type": "MedicalCode", "code": "D006879", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.437.777.560" } } } ] }, { "@type": "MedicalWebPage", "name": "Phycobilines", "alternateName": "Phycobilins", "url": "https://questionsmedicales.fr/mesh/D052980", "about": { "@type": "MedicalCondition", "name": "Phycobilines", "code": { "@type": "MedicalCode", "code": "D052980", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.468" } } }, { "@type": "MedicalWebPage", "name": "Porphyrinogènes", "alternateName": "Porphyrinogens", "url": "https://questionsmedicales.fr/mesh/D011165", "about": { "@type": "MedicalCondition", "name": "Porphyrinogènes", "code": { "@type": "MedicalCode", "code": "D011165", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.500.700" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Coproporphyrinogènes", "alternateName": "Coproporphyrinogens", "url": "https://questionsmedicales.fr/mesh/D003305", "about": { "@type": "MedicalCondition", "name": "Coproporphyrinogènes", "code": { "@type": "MedicalCode", "code": "D003305", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.500.700.250" } } }, { "@type": "MedicalWebPage", "name": "Uroporphyrinogènes", "alternateName": "Uroporphyrinogens", "url": "https://questionsmedicales.fr/mesh/D014577", "about": { "@type": "MedicalCondition", "name": "Uroporphyrinogènes", "code": { "@type": "MedicalCode", "code": "D014577", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.500.700.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Vertéporfine", "alternateName": "Verteporfin", "url": "https://questionsmedicales.fr/mesh/D000077362", "about": { "@type": "MedicalCondition", "name": "Vertéporfine", "code": { "@type": "MedicalCode", "code": "D000077362", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.500.940" } } } ], "about": { "@type": "MedicalCondition", "name": "Tétrapyrroles", "alternateName": "Tetrapyrroles", "code": { "@type": "MedicalCode", "code": "D045725", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Bernhard Grimm", "url": "https://questionsmedicales.fr/author/Bernhard%20Grimm", "affiliation": { "@type": "Organization", "name": "Institute of Biology/Plant Physiology, Humboldt-Universität zu Berlin, Philippstraße 13, Berlin, 10115, Germany." } }, { "@type": "Person", "name": "Jonathan S Lindsey", "url": "https://questionsmedicales.fr/author/Jonathan%20S%20Lindsey", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, North Carolina State University, Raleigh, NC 27695-8204, USA." } }, { "@type": "Person", "name": "Masahiko Taniguchi", "url": "https://questionsmedicales.fr/author/Masahiko%20Taniguchi", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, North Carolina State University, Raleigh, NC 27695-8204, USA." } }, { "@type": "Person", "name": "Joel Rosenthal", "url": "https://questionsmedicales.fr/author/Joel%20Rosenthal", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Biochemistry, Brown Laboratory, University of Delaware, Newark, DE 19716, USA. joelr@udel.edu." } }, { "@type": "Person", "name": "Boris Hedtke", "url": "https://questionsmedicales.fr/author/Boris%20Hedtke", "affiliation": { "@type": "Organization", "name": "Institute of Biology/Plant Physiology, Humboldt-Universität zu Berlin, Philippstraße 13, Berlin, 10115, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Psychometric Evaluation of a Measure of Evidence-Based Practice in Occupational Health.", "datePublished": "2024-10-24", "url": "https://questionsmedicales.fr/article/39450632", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.23749/mdl.v115i5.16286" } }, { "@type": "ScholarlyArticle", "name": "Change in orthopaedic surgeon behaviour by implementing evidence-based practice.", "datePublished": "2023-05-16", "url": "https://questionsmedicales.fr/article/37341352", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": null } }, { "@type": "ScholarlyArticle", "name": "Reducing the incidence of stroke-associated pneumonia: an evidence-based practice.", "datePublished": "2022-08-11", "url": "https://questionsmedicales.fr/article/35953801", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12883-022-02826-8" } }, { "@type": "ScholarlyArticle", "name": "Adaptation and validation of the Evidence-based Practice Profile Questionnaire (EBP", "datePublished": "2023-08-21", "url": "https://questionsmedicales.fr/article/37605185", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-023-04594-6" } }, { "@type": "ScholarlyArticle", "name": "Investigating the influencing factors of evidence-based healthcare practice adoption.", "datePublished": "2024-09-12", "url": "https://questionsmedicales.fr/article/39354780", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4102/curationis.v47i1.2586" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés polycycliques", "item": "https://questionsmedicales.fr/mesh/D011083" }, { "@type": "ListItem", "position": 3, "name": "Composés macrocycliques", "item": "https://questionsmedicales.fr/mesh/D047028" }, { "@type": "ListItem", "position": 4, "name": "Tétrapyrroles", "item": "https://questionsmedicales.fr/mesh/D045725" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tétrapyrroles - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tétrapyrroles", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tétrapyrroles", "description": "Comment diagnostiquer une carence en tétrapyrroles ?\nQuels examens sont utilisés pour évaluer les tétrapyrroles ?\nQuels symptômes indiquent un déséquilibre des tétrapyrroles ?\nLes tests génétiques sont-ils utiles pour les tétrapyrroles ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Evidence-Based+Practice&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tétrapyrroles", "description": "Quels sont les symptômes courants des troubles des tétrapyrroles ?\nComment les tétrapyrroles affectent-ils le système nerveux ?\nLes troubles digestifs sont-ils liés aux tétrapyrroles ?\nLa photosensibilité est-elle un symptôme des tétrapyrroles ?\nLes symptômes varient-ils selon le type de tétrapyrroles ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Evidence-Based+Practice&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tétrapyrroles", "description": "Comment prévenir les crises liées aux tétrapyrroles ?\nLes tests de dépistage sont-ils recommandés ?\nL'éducation des patients est-elle importante ?\nLes vaccinations sont-elles nécessaires pour ces patients ?\nComment le suivi médical régulier aide-t-il ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Evidence-Based+Practice&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tétrapyrroles", "description": "Quels traitements sont disponibles pour les troubles des tétrapyrroles ?\nLa photothérapie est-elle efficace pour les tétrapyrroles ?\nLes suppléments de fer sont-ils recommandés ?\nComment la gestion du stress aide-t-elle les patients ?\nLes changements alimentaires sont-ils bénéfiques ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Evidence-Based+Practice&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tétrapyrroles", "description": "Quelles sont les complications possibles des tétrapyrroles ?\nLes troubles psychologiques sont-ils des complications ?\nComment les tétrapyrroles affectent-ils le foie ?\nLes complications cardiovasculaires sont-elles possibles ?\nLes infections sont-elles une complication fréquente ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Evidence-Based+Practice&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tétrapyrroles", "description": "Quels sont les facteurs de risque des troubles des tétrapyrroles ?\nL'alimentation joue-t-elle un rôle dans les tétrapyrroles ?\nLes maladies hépatiques sont-elles un facteur de risque ?\nLe stress peut-il aggraver les symptômes ?\nLes infections antérieures influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Evidence-Based+Practice&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en tétrapyrroles ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests sanguins mesurant les niveaux de porphyrines." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les tétrapyrroles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de porphyrines urinaires et sanguines sont couramment utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un déséquilibre des tétrapyrroles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des troubles neurologiques et des photosensibilités peuvent survenir." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les tétrapyrroles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent identifier des mutations liées aux troubles des tétrapyrroles." } }, { "@type": "Question", "name": "Quelle est l'importance de l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des facteurs de risque et des antécédents familiaux." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des troubles des tétrapyrroles ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleurs abdominales, éruptions cutanées et fatigue." } }, { "@type": "Question", "name": "Comment les tétrapyrroles affectent-ils le système nerveux ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des neuropathies, des crises et des troubles mentaux." } }, { "@type": "Question", "name": "Les troubles digestifs sont-ils liés aux tétrapyrroles ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs abdominales et des nausées sont fréquentes dans ces troubles." } }, { "@type": "Question", "name": "La photosensibilité est-elle un symptôme des tétrapyrroles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la photosensibilité est un symptôme courant, provoquant des éruptions cutanées." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de tétrapyrroles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type de porphyrie et sa gravité." } }, { "@type": "Question", "name": "Comment prévenir les crises liées aux tétrapyrroles ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les déclencheurs connus, comme certains médicaments et l'alcool, aide à prévenir." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage peut être utile pour les personnes à risque ou avec des antécédents familiaux." } }, { "@type": "Question", "name": "L'éducation des patients est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comprendre la maladie aide les patients à gérer leurs symptômes et à éviter les crises." } }, { "@type": "Question", "name": "Les vaccinations sont-elles nécessaires pour ces patients ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent prévenir des infections qui aggravent les symptômes." } }, { "@type": "Question", "name": "Comment le suivi médical régulier aide-t-il ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier permet d'ajuster les traitements et de surveiller l'évolution de la maladie." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles des tétrapyrroles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments, des transfusions et des thérapies de soutien." } }, { "@type": "Question", "name": "La photothérapie est-elle efficace pour les tétrapyrroles ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la photothérapie peut aider à réduire les symptômes de photosensibilité." } }, { "@type": "Question", "name": "Les suppléments de fer sont-ils recommandés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être nécessaires en cas d'anémie, mais doivent être prescrits par un médecin." } }, { "@type": "Question", "name": "Comment la gestion du stress aide-t-elle les patients ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La gestion du stress peut réduire les crises et améliorer la qualité de vie." } }, { "@type": "Question", "name": "Les changements alimentaires sont-ils bénéfiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un régime équilibré peut aider à gérer les symptômes et améliorer la santé." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des tétrapyrroles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions nerveuses, des problèmes hépatiques et des anémies." } }, { "@type": "Question", "name": "Les troubles psychologiques sont-ils des complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme l'anxiété et la dépression peuvent survenir chez ces patients." } }, { "@type": "Question", "name": "Comment les tétrapyrroles affectent-ils le foie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des lésions hépatiques, entraînant des douleurs et des dysfonctionnements." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes cardiovasculaires peuvent survenir en raison de l'anémie et du stress." } }, { "@type": "Question", "name": "Les infections sont-elles une complication fréquente ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections peuvent survenir, surtout si le système immunitaire est affaibli." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque des troubles des tétrapyrroles ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, l'exposition à des toxines et certains médicaments augmentent le risque." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans les tétrapyrroles ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en nutriments essentiels peut augmenter le risque de troubles." } }, { "@type": "Question", "name": "Les maladies hépatiques sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies hépatiques préexistantes peuvent exacerber les troubles des tétrapyrroles." } }, { "@type": "Question", "name": "Le stress peut-il aggraver les symptômes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress est un facteur déclenchant connu pour les crises liées aux tétrapyrroles." } }, { "@type": "Question", "name": "Les infections antérieures influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent déclencher ou aggraver les troubles des tétrapyrroles." } } ] } ] }

Sources (10000 au total)

Psychometric Evaluation of a Measure of Evidence-Based Practice in Occupational Health.

Occupational Health Services (OHS) are obliged to follow the principles of evidence-based medicine. However, there needs to be tools to measure this. Therefore, we developed and validated a questionna... The questionnaire's content validity was assessed by 12 experts in the field. Then, an opportunity sample of 549 OHS practitioners completed the questionnaire. We examined the questionnaire's psychome... The content validity index of the chosen items was 0.78 or higher. Exploratory factor analysis revealed that the measure's construct validity was adequate (KMO 0.9). Principal component factor analysi... The EBP-OHS is a valid tool for measuring occupational health services' evidence-based practice and enabling the implementation of research into practice. It embodies the phases of evidence transfer a...

Change in orthopaedic surgeon behaviour by implementing evidence-based practice.

Orthopaedic practice is not always aligned with new evidence which may result in an evidence-practice gap. Our aim was to present and report the use of a new model for implementation of evidence-based... A new implementation model from the Centre for Evidence-Based Orthopaedics (CEBO) was applied. It comprises four phases: 1) baseline practice is held up against best available evidence, and barriers t... Prior to application of the CEBO model, only VLP was used in the department. Based on best evidence, the symposium found that a change in practice was justified. A local guideline stating CRPP as firs... It is feasible to change surgeons' practice according to best evidence using the CEBO model.... None.... Not relevant....

Reducing the incidence of stroke-associated pneumonia: an evidence-based practice.

Pulmonary infection is a frequent complication among stroke patients and adversely affects clinical outcomes, increases the length of hospitalization stay and costs, and aggravates the financial burde... The evidence-based practice project evaluated the effectiveness of a standard care bundle intervention in preventing the occurrence of SAP.... The project was conducted in a neurology department of a teaching hospital. Given the variation in assessment and management standards, evidence-based practice (EBP) methodology was used to establish ... A significant improvement was observed in preventing SAP in patients in the postimplementation group compared with those in the preimplementation group (14.0% vs. 37.2%, p = 0.025). In addition, signi... Evidence-based care bundles successfully empower nurses to reduce the incidence of SAP. The management flow of SAP prevention could be promoted to other units of the neurology department in the future...

Adaptation and validation of the Evidence-based Practice Profile Questionnaire (EBP

Evidence-based practice (EBP) is an essential approach of optimizing patient outcomes and driving progress in clinical practice. As an important reserve talent of medical staff and researchers, the cl... Cross-cultural modification, including translating the original EBP... The Chinese EBP... Chinese version of EBP...

Investigating the influencing factors of evidence-based healthcare practice adoption.

In healthcare facilities, evidence-based healthcare practice (EBHP) is becoming more widely acknowledged as a critical element of patient care delivery. An increasingly important component of EBHP is ... This study aims to investigate factors that influence EBHP adoption in public healthcare institutions in South Africa.... Four hundred and fifty patients were self-administered to healthcare professionals at an academic public hospital in Gauteng and used in this study. A total of 300 responses were available for use in ... Perceived ease of use (PEOU) and perceived usefulness (PU) were found to be major variables in the adoption of EBHP along with technological, organisational and environmental factors. The technology c... Perceived ease of use, PU, ORGR, and GLRS are regarded as a vital variables in the implementation of EBHP in South African public hospitals.Contribution: The study's conclusions would be helpful to po...

A Study of Medical Surgical Nurses Leaders' Evidence-Based Practice Attributes: Critical Implications for Practice.

The purpose of this study was to determine medical-surgical nurse leaders' evidence-based practice (EBP) attributes, perceived barriers to EBP, and whether there were differences in leaders' EBP compe... Leaders are crucial to the development of cultures that support EBP implementation, but little is known about medical-surgical nurse leaders' capacity to perform this aspect of their role.... A cross-sectional design using survey methodology was used. The survey contained demographic/work setting questions and 3 instruments to measure EBP beliefs, implementation, and competencies.... Senior leaders self-reported higher EBP attributes compared with nurses in other roles; nurses with an MSN or higher reported greater frequency of EBP implementation. A regression revealed that EBP co... Findings demonstrate there is a range of EBP beliefs and competencies, and barriers to EBP among medical-surgical nurse leaders. Because medical-surgical nursing is the largest acute care practice spe...

Evidence- based physiotherapy practice in Jordan: Evaluation and identification of implementation factors.

Evidence-based physiotherapy practice (EBPTP) is becoming increasingly important to improve patient outcomes and clinical decision-making in the physiotherapy profession.... To evaluate the EBPTP in Jordan and identify the barriers to its implementation in clinical practice.... The study used a cross-sectional survey of licensed physiotherapists working in Jordan using EBPTP self-reported questionnaire. Frequencies, percentages, and one sample Wilcoxon rank test were used to... A total of 210 participants completed the survey. All EBPTP questionnaire elements showed significant positive levels (p = .00) except facility support reflecting non-significant negative level (p = .... The findings confirm a clear gap in EBPTP implementation among physiotherapists in Jordan. The EBPTP implementation factors were mainly based on education sectors and work facilities. Engagement of st...

Evidence-based practice models and frameworks in the healthcare setting: a scoping review.

The aim of this scoping review was to identify and review current evidence-based practice (EBP) models and frameworks. Specifically, how EBP models and frameworks used in healthcare settings align wit... A Scoping review.... Published articles were identified through searches within electronic databases (MEDLINE, EMBASE, Scopus) from January 1990 to April 2022. The English language EBP models and frameworks included in th... Of the 20 097 articles found by our search, 19 models and frameworks met our inclusion criteria. The results showed a diverse collection of models and frameworks. Many models and frameworks were well ... Many EBP models and frameworks currently exist that provide diverse instructions on the best way to use EBP. However, the inclusion of patient values and preferences needs to be better integrated into...

Neurocheck Frequency: Determining Perceptions and Barriers to Implementation of Evidence-Based Practice.

Following acute brain injury, patients in the intensive care unit often undergo hourly or every-other-hour exams ("neurochecks") to monitor for neurodeterioration. We assessed health care provider att... This was a cross-sectional, online survey distributed in Spring 2021 at a tertiary care academic medical center. Providers from multiple intensive care unit and neuroscience clinical specialties inclu... Among 177 participants, 61 (34%) and 116 (66%) were self-identified as ordering and performing providers, respectively. The survey response rate was 58% among physicians and 51% among bedside nurses w... This survey revealed clinically relevant differences in ordering versus performing provider attitudes about frequent neurochecks. Providers preferred every-other-hour rather than hourly neurochecks....